Summary
Updated Aug 31, 2026
Kevin Raymond Merrill Smith is CEO and President of Inogen Inc (INGN). 4 SEC Form 4 filings on record going back to 2024, most recently on 3 March 2026.
Recent Transactions
12Every recent SEC Form 4 transaction Kevin Raymond Merrill Smith has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Kevin Raymond Merrill Smith go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin Raymond Merrill Smith files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Boyer Jennifer M. Yi - $142K of INGN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Kevin Raymond Merrill Smith?
Kevin Raymond Merrill Smith is a corporate insider, tracked as CEO and President of Inogen Inc (INGN). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kevin Raymond Merrill Smith last file a Form 4?
The most recent primary Form 4 on record is dated 3 March 2026, one of 4 filings going back to 2024.
Where can I see all of Kevin Raymond Merrill Smith's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Kevin Raymond Merrill Smith and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial